Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- CBI.TA
- Price
- 29.60
- Stock movement up
- +1.40 (4.96%)
- Company name
- Clal Biotechnology Industries Ltd
- Exchange
- (TA ,
- Currency
- ILA )
- Sector
- Healthcare >Biotechnology
- Market cap
- 4.64B
- Ent value
- 4.67B
- Price/Sales
- 16064.50
- Price/Book
- 38.24
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -6.61%
- 1 year return
- -31.95%
- 3 year return
- -37.11%
- 5 year return
- -18.01%
- 10 year return
- -20.14%
Last updated: 2025-04-12
DIVIDENDS
CBI.TA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 16064.50 |
| Price to Book | 38.24 |
| EV to Sales | 16172.63 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 156.85M |
| EPS (TTM) | -0.18 |
| FCF per share (TTM) | -0.14 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 289.00K |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -6.84M |
| Net income (TTM) | -27.89M |
| EPS (TTM) | -0.18 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | -2367.47% |
| Profit margin (TTM) | -9651.56% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 5.73M |
| Net receivables | 0.00 |
| Total current assets | 14.69M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 4.73M |
| Total assets | 158.39M |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 6.66M |
| Total liabilities | 36.98M |
| Shareholder's equity | 121.41M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -21.82M |
| Capital expenditures (TTM) | 288.00K |
| Free cash flow (TTM) | -22.11M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -22.97% |
| Return on Assets | -17.61% |
| Return on Invested Capital | -18.93% |
| Cash Return on Invested Capital | -15.00% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 29.50 |
| Daily high | 30.50 |
| Daily low | 29.50 |
| Daily Volume | 31K |
| All-time high | 2083.94 |
| 1y analyst estimate | 30.00 |
| Beta | 0.72 |
| EPS (TTM) | -0.18 |
| Dividend per share | - |
| Ex-div date | 29 Mar 2021 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CBI.TA | S&P500 | |
| Current price drop from All-time high | -98.58% | -14.41% |
| Highest price drop | -98.65% | -56.47% |
| Date of highest drop | 9 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -69.64% | -11.07% |
| Avg time to new high | 112 days | 12 days |
| Max time to new high | 3680 days | 1805 days |
COMPANY DETAILS
Marketcap
4.64B
Marketcap category
Mid-cap
Description
Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to invest in companies based in United States, and Israel. It takes a seat on the board of directors of the companies it invests in. It invests through personal capital of its management. The firm acts as a lead investor and major shareholder in its portfolio companies. Clal Biotechnology Industries Ltd. was founded in July, 1998 and is based in Tel Aviv, Israel with an additional offices in Boston, Massachusetts and Cambridge, Massachusetts. It operates as a former subsidiary of Clal Industries and Investments Ltd.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
Israel
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found